MLMSX
Price
$23.68
Change
+$0.07 (+0.30%)
Updated
Aug 13 closing price
Net Assets
46.49M
RNPHX
Price
$71.04
Change
+$0.20 (+0.28%)
Updated
Aug 13 closing price
Net Assets
158.79B
Interact to see
Advertisement

MLMSX vs RNPHX

Header iconMLMSX vs RNPHX Comparison
Open Charts MLMSX vs RNPHXBanner chart's image
Morgan Stanley Instl Global Core R6
Price$23.68
Change+$0.07 (+0.30%)
VolumeN/A
Net Assets46.49M
American Funds New Perspective R5E
Price$71.04
Change+$0.20 (+0.28%)
VolumeN/A
Net Assets158.79B
MLMSX vs RNPHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MLMSX vs. RNPHX commentary
Aug 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLMSX is a Buy and RNPHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 159B vs. MLMSX (46.5M). RNPHX pays higher dividends than MLMSX: RNPHX (0.66) vs MLMSX (0.20). MLMSX was incepted earlier than RNPHX: MLMSX (9 years) vs RNPHX (10 years). MLMSX (20.37) is less costly to investors than RNPHX (0.56). MLMSX is a more actively managed with annual turnover of: 39.00 vs. RNPHX (24.00). RNPHX has a lower initial minimum investment than MLMSX: RNPHX (250) vs MLMSX (5000000). MLMSX annual gain was more profitable for investors over the last year : 20.65 vs. RNPHX (16.06). MLMSX return over 5 years is better than : 72.04 vs. RNPHX (39.10).
MLMSXRNPHXMLMSX / RNPHX
Total Expense Ratio0.950.56170%
Annual Report Gross Expense Ratio20.370.563,638%
Fund Existence9 years10 years-
Gain YTD12.48215.62580%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets46.5M159B0%
Annual Yield % from dividends0.200.6630%
Returns for 1 year20.6516.06129%
Returns for 3 years52.6235.09150%
Returns for 5 years72.0439.10184%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNLI14.811.59
+12.03%
Denali Therapeutics
SNX153.583.10
+2.06%
TD SYNNEX Corp
OPXS12.150.15
+1.25%
Optex Systems Holdings
ISPC1.160.01
+0.87%
iSpecimen Inc
LAB1.31N/A
N/A
Standard BioTools